BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2013; 19(40): 6911-6918 [PMID: 24187469 DOI: 10.3748/wjg.v19.i40.6911]
URL: https://www.wjgnet.com/1007-9327/full/v19/i40/6911.htm
Number Citing Articles
1
Brian A. Nadeau, Hari Conjeevaram. The gut microbiome and nonalcoholic fatty liver diseaseClinical Liver Disease 2017; 10(5): 116 doi: 10.1002/cld.671
2
Surender Jangra, Ramesh Pothuraju. Microbial Diversity, Interventions and Scope2020; : 321 doi: 10.1007/978-981-15-4099-8_18
3
Kareem Hassan, Varun Bhalla, Mohammed Ezz El Regal, H Hesham A-Kader. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemicWorld Journal of Gastroenterology 2014; 20(34): 12082-12101 doi: 10.3748/wjg.v20.i34.12082
4
Neerja Hajela, B. S. Ramakrishna, G. Balakrish Nair, Philip Abraham, Sarath Gopalan, Nirmal K. Ganguly. Gut microbiome, gut function, and probiotics: Implications for healthIndian Journal of Gastroenterology 2015; 34(2): 93 doi: 10.1007/s12664-015-0547-6
5
Stavros Bashiardes, Hagit Shapiro, Shachar Rozin, Oren Shibolet, Eran Elinav. Non-alcoholic fatty liver and the gut microbiotaMolecular Metabolism 2016; 5(9): 782 doi: 10.1016/j.molmet.2016.06.003
6
Claudio Hidalgo-Cantabrana, Susana Delgado, Lorena Ruiz, Patricia Ruas-Madiedo, Borja Sánchez, Abelardo Margolles. Bugs as Drugs2018; : 73 doi: 10.1128/9781555819705.ch3
7
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathyCochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
8
Yong Kyun Cho. Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?Clinical and Molecular Hepatology 2018; 24(3): 299 doi: 10.3350/cmh.2018.1006
9
Muhammad Y. Khan, Albana B. Mihali, Muhammad S. Rawala, Aysha Aslam, Waqas J. Siddiqui. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease – a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology 2019; 31(6): 703 doi: 10.1097/MEG.0000000000001371
10
Noreen Neuwirth, Samuel Kochenburger, Christian Sina. Mikrobiom und metabolische Fettlebererkrankung (MeFLD)Der Diabetologe 2021; 17(4): 391 doi: 10.1007/s11428-021-00725-z
11
Maria Grazia Clemente, Claudia Mandato, Marco Poeta, Pietro Vajro. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directionsWorld Journal of Gastroenterology 2016; 22(36): 8078-8093 doi: 10.3748/wjg.v22.i36.8078
12
Ibrahim G. Saleh, Zulfiqar Ali, Naohito Abe, Farid M. Hamada, Mohamed F. Abd-Ellah, Larry A. Walker, Ikhlas A. Khan, Mohammad K. Ashfaq. Possible hepatocellular toxicity of EGCG under the influence of an inflammagenJournal of Applied Biomedicine 2014; 12(4): 291 doi: 10.1016/j.jab.2014.03.001
13
C. Punzalan, A. Qamar. The Microbiota in Gastrointestinal Pathophysiology2017; : 373 doi: 10.1016/B978-0-12-804024-9.00040-9
14
Cat. Buffet, Cam. Buffet. Les hépatopathies stéatosiques non alcooliques et le microbiote intestinalMédecine des Maladies Métaboliques 2015; 9(3): 301 doi: 10.1016/S1957-2557(15)30078-X
15
Pramodini Kale-Pradhan, Sheila Wilhelm. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th Edition2017;  doi: 10.21019/9781582122656.ch20
16
Ali Abdul-Hai, Ali Abdallah, Stephen DH Malnick. Influence of gut bacteria on development and progression of non-alcoholic fatty liver diseaseWorld Journal of Hepatology 2015; 7(12): 1679-1684 doi: 10.4254/wjh.v7.i12.1679
17
Jun-Ling Han, Hui-Ling Lin. Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspectiveWorld Journal of Gastroenterology 2014; 20(47): 17737-17745 doi: 10.3748/wjg.v20.i47.17737
18
Silvia Ferolla, Geyza Armiliato, Cláudia Couto, Teresa Ferrari. The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver DiseaseNutrients 2014; 6(12): 5583 doi: 10.3390/nu6125583
19
Zhe Zhang, Hui Zhou, Xiaohong Zhou, Jize Sun, Xi Liang, Youyou Lv, Lu Bai, Junxue Zhang, Pimin Gong, Tongjie Liu, Huaxi Yi, Jingfeng Wang, Lanwei Zhang. Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathwayBritish Journal of Nutrition 2021; 125(5): 521 doi: 10.1017/S0007114520003001
20
Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty. A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7109270
21
Giulia Paolella, Claudia Mandato, Luca Pierri, Marco Poeta, Martina Di Stasi, Pietro Vajro. Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(42): 15518-15531 doi: 10.3748/wjg.v20.i42.15518
22
Anne Sophie Schneck, Rodolphe Anty, Albert Tran, Audrey Hastier, Imed Ben Amor, Jean Gugenheim, Antonio Iannelli, Thierry Piche. Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric SurgeryObesity Surgery 2016; 26(7): 1525 doi: 10.1007/s11695-015-1907-0
23
Hannele Yki-Järvinen. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease2016; : 189 doi: 10.1002/9781118924938.ch21
24
Vanessa Stadlbauer-Köllner. Probiotika bei LebererkrankungenWiener klinisches Magazin 2018; 21(6): 240 doi: 10.1007/s00740-018-0250-1
25
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic DiseasesJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00131
26
Diptadip Dattaroy, Ratanesh Kumar Seth, Suvarthi Das, Firas Alhasson, Varun Chandrashekaran, Gregory Michelotti, Daping Fan, Mitzi Nagarkatti, Prakash Nagarkatti, Anna Mae Diehl, Saurabh Chatterjee. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(7): G510 doi: 10.1152/ajpgi.00259.2015
27
Qingqing Zhang, Yucheng Wu, Xiaoqiang Fei. Effect of probiotics on body weight and body-mass index: a systematic review and meta-analysis of randomized, controlled trialsInternational Journal of Food Sciences and Nutrition 2016; 67(5): 571 doi: 10.1080/09637486.2016.1181156
28
S. Fine, C.R. Kelly. The Microbiota in Gastrointestinal Pathophysiology2017; : 315 doi: 10.1016/B978-0-12-804024-9.00034-3
29
J. P. Ong, Z. M. Younossi. Editorial: probiotics in NASH - more studies are neededAlimentary Pharmacology & Therapeutics 2014; 40(2): 211 doi: 10.1111/apt.12812
30
Saumya Jayakumar, Rohit Loomba. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implicationsAlimentary Pharmacology & Therapeutics 2019; 50(2): 144 doi: 10.1111/apt.15314
31
Frank Tacke, Ralf Weiskirchen. An update on the recent advances in antifibrotic therapyExpert Review of Gastroenterology & Hepatology 2018; 12(11): 1143 doi: 10.1080/17474124.2018.1530110
32
Liang Liu, Ping Li, Yiqi Liu, Yilian Zhang. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-AnalysisDigestive Diseases and Sciences 2019; 64(12): 3402 doi: 10.1007/s10620-019-05699-z
33
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. Consenso mexicano sobre probióticos en gastroenterologíaRevista de Gastroenterología de México 2017; 82(2): 156 doi: 10.1016/j.rgmx.2016.08.004
34
Floriana Elvira Ionică, Simona Negreș, Ludovic Bejenaru, Cornelia Bejenaru, Cornel Chiriță. Pharmacological Approaches for Nonalcoholic Fatty Liver DiseaseRomanian Journal of Diabetes Nutrition and Metabolic Diseases 2016; 23(3) doi: 10.1515/rjdnmd-2016-0037
35
İhsan Boyacı, Süleyman Yıldırım. Metabolik Sendrom Tedavisinde Bağırsak Mikrobiyotasının Probiyotikler ve Özelinde Saccharomyces Boulardii ile ModülasyonuAnadolu Kliniği Tıp Bilimleri Dergisi 2017;  doi: 10.21673/anadoluklin.260702
36
Brandon Perumpail, Andrew Li, Nimy John, Sandy Sallam, Neha Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLDDiseases 2019; 7(1): 27 doi: 10.3390/diseases7010027
37
Louis H. S. Lau, Sunny H. Wong. Obesity, Fatty Liver and Liver CancerAdvances in Experimental Medicine and Biology 2018; 1061: 111 doi: 10.1007/978-981-10-8684-7_9
38
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. The Mexican consensus on probiotics in gastroenterologyRevista de Gastroenterología de México (English Edition) 2017; 82(2): 156 doi: 10.1016/j.rgmxen.2017.03.003
39
Reiner Wiest, Agustin Albillos, Michael Trauner, Jasmohan S. Bajaj, Rajiv Jalan. Targeting the gut-liver axis in liver diseaseJournal of Hepatology 2017; 67(5): 1084 doi: 10.1016/j.jhep.2017.05.007
40
Claudio Hidalgo-Cantabrana, Susana Delgado, Lorena Ruiz, Patricia Ruas-Madiedo, Borja Sánchez, Abelardo Margolles, Robert Allen Britton, Patrice D. Cani. Bifidobacteria and Their Health-Promoting EffectsMicrobiology Spectrum 2017; 5(3) doi: 10.1128/microbiolspec.BAD-0010-2016
41
Nikita Khanna, Priyanka Devi, Anil Kumar, Sandip V. Pawar. Probiotic Research in Therapeutics2021; : 335 doi: 10.1007/978-981-33-6236-9_15
42
Atefe Asgharian, Vida Mohammadi, Zahra Gholi, Ahmad Esmaillzade, Awat Feizi, Gholamreza Askari. The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients with NAFLD: A Randomized, Double Blind, Placebo-Controlled Clinical Trial StudyIranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.42902
43
Grace Hatton, Tommaso Alterio, Valerio Nobili, Jake P. Mann. Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?Expert Review of Gastroenterology & Hepatology 2018; 12(10): 961 doi: 10.1080/17474124.2018.1512853
44
Beng San Yeoh, Matam Vijay-Kumar. Mechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases2018; : 129 doi: 10.1007/978-1-4939-7534-1_7
45
Jag Khalsa, Linda C. Duffy, Gabriela Riscuta, Pamela Starke-Reed, Van S. Hubbard. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision MedicineClinical Pharmacology in Drug Development 2017; 6(2): 176 doi: 10.1002/cpdd.310
46
Michelle L. Dossett, Ezra M. Cohen, Jonah Cohen. Integrative Medicine for Gastrointestinal DiseasePrimary Care: Clinics in Office Practice 2017; 44(2): 265 doi: 10.1016/j.pop.2017.02.002
47
Mariangela Rondanelli, Milena Anna Faliva, Simone Perna, Attilio Giacosa, Gabriella Peroni, Anna Maria Castellazzi. Using probiotics in clinical practice: Where are we now? A review of existing meta-analysesGut Microbes 2017; 8(6): 521 doi: 10.1080/19490976.2017.1345414
48
Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol, Ganesh Narayan Ramesh, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar. Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver DiseaseJournal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00035
49
Rosângela Passos de Jesus, Naiara Brunelle Oliveira Neiva, Thomas Thássio Rodrigues de Araújo Silva. A síndrome metabólica e suas implicações clínicas2018; : 139 doi: 10.7476/9786588211113.0007
50
György M. Buzás. Helicobacter pylori and non-alcoholic fatty liver diseaseMinerva Gastroenterologica e Dietologica 2020; 66(3) doi: 10.23736/S1121-421X.20.02671-9
51
Alessandro Federico, Claudio Zulli, Ilario de Sio, Anna Del Prete, Marcello Dallio, Mario Masarone, Carmela Loguercio. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(45): 16841-16857 doi: 10.3748/wjg.v20.i45.16841
52
Masami Minemura, Yukihiro Shimizu. Gut microbiota and liver diseasesWorld Journal of Gastroenterology 2015; 21(6): 1691-1702 doi: 10.3748/wjg.v21.i6.1691
53
Abdolmajid Ghasemian, Majid Eslami, Morvarid Shafiei, Sohrab Najafipour, Ali Rajabi. Probiotics and their increasing importance in human health and infection controlReviews in Medical Microbiology 2018; 29(4): 153 doi: 10.1097/MRM.0000000000000147
54
Claudia Della Corte, Pietro Vajro, Piotr Socha, Valerio Nobili. Pediatric non-alcoholic fatty liver disease: Recent advancesClinics and Research in Hepatology and Gastroenterology 2014; 38(4): 419 doi: 10.1016/j.clinre.2014.02.008
55
Amanda Chaney. Treating the patient with nonalcoholic fatty liver diseaseThe Nurse Practitioner 2015; 40(11): 36 doi: 10.1097/01.NPR.0000472248.28703.18
56
Gina P. Rodriguez-Castaño, Alejandro Caro-Quintero, Alejandro Reyes, Fernando Lizcano. Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western LifestyleFrontiers in Genetics 2017; 7 doi: 10.3389/fgene.2016.00224
57
Na Young Lee, Sang Jun Yoon, Dae Hee Han, Haripriya Gupta, Gi Soo Youn, Min Jea Shin, Young Lim Ham, Min Jung Kwak, Byung Yong Kim, Jeong Seok Yu, Do Yup Lee, Tae-Sik Park, Si-Hyun Park, Byoung Kook Kim, Hyun Chae Joung, In Suk Choi, Ji Taek Hong, Dong Joon Kim, Sang Hak Han, Ki Tae Suk. Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiomeGut Microbes 2020; 11(4): 882 doi: 10.1080/19490976.2020.1712984
58
Céline Druart, Maud Alligier, Nuria Salazar, Audrey M. Neyrinck, Nathalie M. Delzenne. Modulation of the Gut Microbiota by Nutrients with Prebiotic and Probiotic PropertiesAdvances in Nutrition 2014; 5(5): 624S doi: 10.3945/an.114.005835
59
Uday C. Ghoshal, Chalamalasetty Sreenivasa Baba, Ujjala Ghoshal, George Alexander, Asha Misra, Vivek A Saraswat, Gourdas Choudhuri. Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate cultureIndian Journal of Gastroenterology 2017; 36(5): 390 doi: 10.1007/s12664-017-0797-6
60
Nadia Juliana Beraldo Goulart Borges Haubert, Julio Sergio Marchini, Selma Freire Carvalho Cunha, Vivian Marques Miguel Suen, Gilberto Joao Padovan, Alceu Afonso Jordao Junior, Claudia Maria Meirelles Marchini Alves, Julio Flavio Meirelles Marchini, Helio Vannucchi. Choline and Fructooligosaccharide: Non-alcoholic Fatty Liver Disease, Cardiac Fat Deposition, and Oxidative Stress MarkersNutrition and Metabolic Insights 2015; 8: NMI.S24385 doi: 10.4137/NMI.S24385
61
Brett R Loman, Diego Hernández-Saavedra, Ruopeng An, R Scott Rector. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysisNutrition Reviews 2018; 76(11): 822 doi: 10.1093/nutrit/nuy031
62
Yu. M. Stepanov, I. V. Psareva, O. M. Tatarchuk, E. V. Zygalo, O. P. Petishko. LEVELS OF INTESTINAL INFLAMMATION MARKERS AS A DIAGNOSTIC CRITERION FOR FORMING A RISK GROUP FOR IDENTIFICATION OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN ULCER COLIT Bulletin of Problems Biology and Medicine 2020; 4(2): 204 doi: 10.29254/2077-4214-2019-4-2-154-204-207
63
Mehri Jamilian, Elaheh Amirani, Zatollah Asemi. The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trialClinical Nutrition 2019; 38(5): 2098 doi: 10.1016/j.clnu.2018.10.028
64
Ahyoung Kim, Arunkumar Krishnan, James P. Hamilton, Tinsay A. Woreta. The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver DiseaseGastroenterology Clinics of North America 2021; 50(1): 217 doi: 10.1016/j.gtc.2020.10.013
65
Haripriya Maddur, Brent A Neuschwander-Tetri. More evidence that probiotics may have a role in treating fatty liver diseaseThe American Journal of Clinical Nutrition 2014; 99(3): 425 doi: 10.3945/ajcn.113.082636
66
Maria Hernandez-Rodas, Rodrigo Valenzuela, Luis Videla. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2015; 16(10): 25168 doi: 10.3390/ijms161025168
67
Davide Festi, Ramona Schiumerini, Leonardo Henry Eusebi, Giovanni Marasco, Martina Taddia, Antonio Colecchia. Gut microbiota and metabolic syndromeWorld Journal of Gastroenterology 2014; 20(43): 16079-16094 doi: 10.3748/wjg.v20.i43.16079
68
Anne-Marie Cassard, Camille Houron, Dragos Ciocan. Microbiote intestinal et stéatopathie métaboliqueNutrition Clinique et Métabolisme 2020; 34(2): 130 doi: 10.1016/j.nupar.2019.12.002
69
IG Saleh, Z Ali, MA Hammad, FD Wilson, FM Hamada, MF Abd-Ellah, LA Walker, IA Khan, MK Ashfaq. Stem cell intervention ameliorates epigallocatechin-3-gallate/lipopolysaccharide-induced hepatotoxicity in miceHuman & Experimental Toxicology 2015; 34(11): 1180 doi: 10.1177/0960327115572707
70
Seyed Mohammad Seifati, Erfan Zaker, Farzaneh Fesahat, Fateme Zare, Seyedhossein Hekmatimoghaddam, Zubeyir Huyut. Modulatory Effect of Probiotics on Proinflammatory Cytokine Levels in Acrylamide-Treated RatsBiochemistry Research International 2021; 2021: 1 doi: 10.1155/2021/2268770
71
M.-Y. Park, S.J. Kim, E.K. Ko, S.-H. Ahn, H. Seo, M.-K. Sung. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob miceJournal of Applied Microbiology 2016; 121(3): 800 doi: 10.1111/jam.13158
72
Yosep Ji, Young Mee Chung, Soyoung Park, Dahye Jeong, Bongjoon Kim, Wilhelm Heinrich Holzapfel. Dose-dependent and strain-dependent anti-obesity effects ofLactobacillus sakeiin a diet induced obese murine modelPeerJ 2019; 7: e6651 doi: 10.7717/peerj.6651
73
Sheila Wilhelm, Pramodini Kale-Pradhan. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition2020;  doi: 10.21019/9781582123172.ch20
74
Grace B. Hatton, Shaolu Ran, Thomas H. Tranah, Debbie L. Shawcross. Lessons Learned from Faecal Microbiota Transplantation in CirrhosisCurrent Hepatology Reports 2020; 19(3): 159 doi: 10.1007/s11901-020-00520-2
75
Carolina M. Perdomo, Gema Frühbeck, Javier Escalada. Impact of Nutritional Changes on Nonalcoholic Fatty Liver DiseaseNutrients 2019; 11(3): 677 doi: 10.3390/nu11030677
76
Nazarii Kobyliak, Ludovico Abenavoli, Tetyana Falalyeyeva, Galyna Mykhalchyshyn, Luigi Boccuto, Liudmyla Kononenko, Dmytro Kyriienko, Iuliia Komisarenko, Oleg Dynnyk. Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical studyMinerva Medica 2018; 109(6) doi: 10.23736/S0026-4806.18.05845-7
77
Carolina M. Perdomo, Nuria Garcia-Fernandez, Javier Escalada. Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?Journal of Clinical Medicine 2021; 10(9): 2040 doi: 10.3390/jcm10092040
78
Song Lin, Shanliang Zhao, Jiahong Liu, Jianwen Zhang, Chao Zhang, Haibo Hao, Yuxia Sun, Jing Cai, Yang Yang, Yan Ma, Yuanyuan Li, Jinyu Wang, Aiguo Ma. Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trialFood & Function 2020; 11(1): 370 doi: 10.1039/C9FO01583C
79
Wei Wang, Ai-Lei Xu, Zheng-Chao Li, Yi Li, Shun-Fu Xu, Hua-Chao Sang, Fachao Zhi. Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD MiceDiabetes & Metabolism Journal 2020; 44(2): 336 doi: 10.4093/dmj.2019.0042
80
Jay Luther, John J. Garber, Hamed Khalili, Maneesh Dave, Shyam Sundhar Bale, Rohit Jindal, Daniel L. Motola, Sanjana Luther, Stefan Bohr, Soung Won Jeoung, Vikram Deshpande, Gurminder Singh, Jerrold R. Turner, Martin L. Yarmush, Raymond T. Chung, Suraj J. Patel. Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal PermeabilityCellular and Molecular Gastroenterology and Hepatology 2015; 1(2): 222 doi: 10.1016/j.jcmgh.2015.01.001
81
Emilia Rusu, Georgiana Enache, Raluca Cursaru, Alexandra Alexescu, Raluca Radu, Oana Onila, Teodora Cavallioti, Florin Rusu, Mihaela Posea, Mariana Jinga, Gabriela Radulian. Prebiotics and probiotics in atopic dermatitis (Review) Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7678
82
Thomas Tu, Magdalena Budzinska, Annette Maczurek, Robert Cheng, Anna Di Bartolomeo, Fiona Warner, Geoffrey McCaughan, Susan McLennan, Nicholas Shackel. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and DevelopmentInternational Journal of Molecular Sciences 2014; 15(6): 9422 doi: 10.3390/ijms15069422
83
Amir Hadi, Hamed Mohammadi, Maryam Miraghajani, Ehsan Ghaedi. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLDCritical Reviews in Food Science and Nutrition 2019; 59(15): 2494 doi: 10.1080/10408398.2018.1458021
84
Ilva Lazda, Angelika Krūmiņa, Indra Zeltiņa, Nikola Krūmiņa, Juris ķibilds, Inese Siksna, Ludmila Vīksna, Aleksejs Derovs. Microbial Community of Kefir and its Impact on the Gastrointestinal Microbiome in Health and DiseaseProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020; 74(2): 58 doi: 10.2478/prolas-2020-0009
85
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
86
Xu Wang, Linlin Shi, Xinping Wang, Yi Feng, Yuan Wang. MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axisInternational Journal of Biological Macromolecules 2019; 141: 1013 doi: 10.1016/j.ijbiomac.2019.09.007
87
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Ryota Masuzaki, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2020; 21(4): 1525 doi: 10.3390/ijms21041525
88
Jessica Tsuei, Thinh Chau, David Mills, Yu-Jui Yvonne Wan. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancerExperimental Biology and Medicine 2014; 239(11): 1489 doi: 10.1177/1535370214538743
89
Anurag S Lavekar, Dhananjay V Raje, Amarja A Lavekar. Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysisEuroasian Journal of Hepato-Gastroenterology 2017; 7(2): 130 doi: 10.5005/jp-journals-10018-1233
90
S Sherf-Dagan, S Zelber-Sagi, G Zilberman-Schapira, M Webb, A Buch, A Keidar, A Raziel, N Sakran, D Goitein, N Goldenberg, J A Mahdi, M Pevsner-Fischer, N Zmora, M Dori-Bachash, E Segal, E Elinav, O Shibolet. Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trialInternational Journal of Obesity 2018; 42(2): 147 doi: 10.1038/ijo.2017.210
91
Jinting Liu, Shuangping Zhen. Protective Effect of Maternal Prebiotics Against Neonatal Jaundice Induced by Phenylhydrazine in RatsInternational Journal of Pharmacology 2019; 15(7): 891 doi: 10.3923/ijp.2019.891.899
92
Hyeyoon Eo, You-jin Jeon, Myoungsook Lee, Yunsook Lim. Brown Alga Ecklonia cava Polyphenol Extract Ameliorates Hepatic Lipogenesis, Oxidative Stress, and Inflammation by Activation of AMPK and SIRT1 in High-Fat Diet-Induced Obese MiceJournal of Agricultural and Food Chemistry 2015; 63(1): 349 doi: 10.1021/jf502830b
93
Manuela G. Neuman, Samuel W. French, Samir Zakhari, Stephen Malnick, Helmut K. Seitz, Lawrence B Cohen, Mikko Salaspuro, Andreea Voinea-Griffin, Andrei Barasch, Irina A. Kirpich, Paul G. Thomes, Laura W. Schrum, Terrence M. Donohue, Kusum K. Kharbanda, Marcus Cruz, Mihai Opris. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damageExperimental and Molecular Pathology 2017; 102(1): 162 doi: 10.1016/j.yexmp.2017.01.003
94
Anne-Marie Cassard, Philippe Gérard, Gabriel Perlemuter. Bugs as Drugs2018; : 187 doi: 10.1128/9781555819705.ch8
95
Mariana Machado, Helena Cortez-Pinto. Diet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetInternational Journal of Molecular Sciences 2016; 17(4): 481 doi: 10.3390/ijms17040481
96
Yanjun Cui, Sirui Qi, Wenming Zhang, Jiangdi Mao, Renlong Tang, Chong Wang, Jianxin Liu, Xin M Luo, Haifeng Wang. Lactobacillus reuteri ZJ617 Culture Supernatant Attenuates Acute Liver Injury Induced in Mice by LipopolysaccharideThe Journal of Nutrition 2019; 149(11): 2046 doi: 10.1093/jn/nxz088
97
Asma Kazemi, Sepideh Soltani, Sima Ghorabi, Abbas Keshtkar, Elnaz Daneshzad, Fatemeh Nasri, Seyed Mohammad Mazloomi. Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trialsClinical Nutrition 2020; 39(3): 789 doi: 10.1016/j.clnu.2019.04.004
98
Maddalena Petraroli, Eleonora Castellone, Viviana Patianna, Susanna Esposito. Gut Microbiota and Obesity in Adults and Children: The State of the ArtFrontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.657020
99
Hamed Ebrahimzadeh Leylabadlo, Reza Ghotaslou, Hossein Samadi Kafil, Mohammad Mehdi Feizabadi, Seyed Yaghoub Moaddab, Safar Farajnia, Elham Sheykhsaran, Sarvin Sanaie, Dariush Shanehbandi, Hossein Bannazadeh Baghi. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapiesEuropean Journal of Clinical Microbiology & Infectious Diseases 2020; 39(4): 613 doi: 10.1007/s10096-019-03746-1
100
Xiao-Fang Yang, Ming Lu, Lijiao You, Huan Gen, Lin Yuan, Tianning Tian, Chun-Yu Li, Kailiang Xu, Jie Hou, Ming Lei. Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecologyChinese Medicine 2021; 16(1) doi: 10.1186/s13020-021-00470-x
101
Anne-Marie Cassard, Philippe Gérard, Gabriel Perlemuter, Robert Allen Britton, Patrice D. Cani. Microbiota, Liver Diseases, and AlcoholMicrobiology Spectrum 2017; 5(4) doi: 10.1128/microbiolspec.BAD-0007-2016
102
Soo Lim, Tae Jung Oh, Kwang Kon Koh. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disordersInternational Journal of Cardiology 2015; 201: 408 doi: 10.1016/j.ijcard.2015.08.107
103
Ivana Milosevic, Ankica Vujovic, Aleksandra Barac, Marina Djelic, Milos Korac, Aleksandra Radovanovic Spurnic, Ivana Gmizic, Olja Stevanovic, Vladimir Djordjevic, Nebojsa Lekic, Edda Russo, Amedeo Amedei. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the LiteratureInternational Journal of Molecular Sciences 2019; 20(2): 395 doi: 10.3390/ijms20020395
104
Carly E Kelley, Ann J Brown, Anna Mae Diehl, Tracy L Setji. Review of nonalcoholic fatty liver disease in women with polycystic ovary syndromeWorld Journal of Gastroenterology 2014; 20(39): 14172-14184 doi: 10.3748/wjg.v20.i39.14172
105
Claudia P. Oliveira, Priscila de Lima Sanches, Erlon Oliveira de Abreu-Silva, Aline Marcadenti. Nutrition and Physical Activity in Nonalcoholic Fatty Liver DiseaseJournal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/4597246
106
Khadijeh Abhari, Saeede Saadati, Zahra Yari, Hedayat Hosseini, Mehdi Hedayati, Shahabeddin Abhari, Seyyed Moayyed Alavian, Azita Hekmatdoost. The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trialClinical Nutrition ESPEN 2020; 39: 53 doi: 10.1016/j.clnesp.2020.06.020
107
Sanjoy Roychowdhury, Praveen Selvakumar, Gail Cresci. The Role of the Gut Microbiome in Nonalcoholic Fatty Liver DiseaseMedical Sciences 2018; 6(2): 47 doi: 10.3390/medsci6020047
108
Jingguo Li, Biguang Tuo, Stefano Gitto. Current and Emerging Approaches for Hepatic Fibrosis TreatmentGastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/6612892
109
Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert. Liver Fibrosis: Mechanistic Concepts and Therapeutic PerspectivesCells 2020; 9(4): 875 doi: 10.3390/cells9040875
110
R. Barazzoni, N.E.P. Deutz, G. Biolo, S. Bischoff, Y. Boirie, T. Cederholm, C. Cuerda, N. Delzenne, M. Leon Sanz, O. Ljungqvist, M. Muscaritoli, C. Pichard, J.C. Preiser, P. Sbraccia, P. Singer, L. Tappy, B. Thorens, A. Van Gossum, R. Vettor, P.C. Calder. Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert groupClinical Nutrition 2017; 36(2): 355 doi: 10.1016/j.clnu.2016.09.010
111
Wenke Feng, Craig McClain. Molecules, Systems and Signaling in Liver Injury2017; : 251 doi: 10.1007/978-3-319-58106-4_11
112
Małgorzata Moszak, Monika Szulińska, Marta Walczak-Gałęzewska, Paweł Bogdański. Nutritional Approach Targeting Gut Microbiota in NAFLD—To DateInternational Journal of Environmental Research and Public Health 2021; 18(4): 1616 doi: 10.3390/ijerph18041616
113
Savinda Liyanagedera, Robert Patrick Williams, Silvio Veraldi, Valerio Nobili, Jake P. Mann. The pharmacological management of NAFLD in children and adolescentsExpert Review of Clinical Pharmacology 2017; 10(11): 1225 doi: 10.1080/17512433.2017.1365599
114
T. Vaikunthanathan, N. Safinia, G. Lombardi, R.I. Lechler. Microbiota, immunity and the liverImmunology Letters 2016; 171: 36 doi: 10.1016/j.imlet.2016.01.008
115
Vishal Singh, Beng San Yeoh, James M. Ntambi, Matam Vijay-Kumar. Hepatic De Novo Lipogenesis and Regulation of Metabolism2016; : 189 doi: 10.1007/978-3-319-25065-6_9
116
R. V. Maslennikov, Yu. V. Evsyutina. Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal MicrobiotaRossijskij žurnal gastroènterologii gepatologii koloproktologii 2018; 28(4): 84 doi: 10.22416/1382-4376-2018-28-4-84-90
117
Laura Baselga-Escudero, Vanessa Souza-Mello, Aïda Pascual-Serrano, Tamiris Rachid, Adriana Voci, Ilaria Demori, Elena Grasselli. Beneficial effects of the Mediterranean spices and aromas on non-alcoholic fatty liver diseaseTrends in Food Science & Technology 2017; 61: 141 doi: 10.1016/j.tifs.2016.11.019
118
Nazarii Kobyliak, Caterina Conte, Giovanni Cammarota, Andreana P. Haley, Igor Styriak, Ludovit Gaspar, Jozef Fusek, Luis Rodrigo, Peter Kruzliak. Probiotics in prevention and treatment of obesity: a critical viewNutrition & Metabolism 2016; 13(1) doi: 10.1186/s12986-016-0067-0
119
Luisa Bonsembiante, Giovanni Targher, Claudio Maffeis. Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition?European Journal of Clinical Nutrition 2021;  doi: 10.1038/s41430-021-00928-z
120
Abdel-Naser Elzouki. Probiotics and Liver DiseaseJournal of Clinical Gastroenterology 2016; 50(Supplement 2): S188 doi: 10.1097/MCG.0000000000000712
121
Alireza Milajerdi, Seyyed Mohammad Mousavi, Alireza Sadeghi, Asma Salari-Moghaddam, Mohammad Parohan, Bagher Larijani, Ahmad Esmaillzadeh. The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trialsEuropean Journal of Nutrition 2020; 59(2): 633 doi: 10.1007/s00394-019-01931-8
122
Silvia M. Ferolla, Cláudia A. Couto, Maria de Lourdes A. Ferrari, Luciana Costa Faria, Murilo Pereira, Teresa C.A. Ferrari. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications2019; : 265 doi: 10.1016/B978-0-12-815249-2.00027-0
123
Fuxi Li, Junzhao Ye, Congxiang Shao, Bihui Zhong. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysisLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01440-w
124
Suzanne E. Mahady, Jacob George. Exercise and diet in the management of nonalcoholic fatty liver diseaseMetabolism 2016; 65(8): 1172 doi: 10.1016/j.metabol.2015.10.032
125
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
126
Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. Reference Module in Food Science2021;  doi: 10.1016/B978-0-12-819265-8.00079-6
127
J. Pang, W. Xu, X. Zhang, G. L.-H. Wong, A. W.-H. Chan, H.-Y. Chan, C.-H. Tse, S. S.-T. Shu, P. C.-L. Choi, H. L.-Y. Chan, J. Yu, V. W.-S. Wong. Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2017; 46(2): 175 doi: 10.1111/apt.14119
128
Matthew T. Goodus, Dana M. McTigue. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?Experimental Neurology 2020; 325: 113160 doi: 10.1016/j.expneurol.2019.113160
129
Fouad M. F. Elshaghabee, Namita Rokana, Harsh Panwar, Knut J. Heller, Jürgen Schrezenmeir. Probiotics for dietary management of non-alcoholic fatty liver diseaseEnvironmental Chemistry Letters 2019; 17(4): 1553 doi: 10.1007/s10311-019-00896-8
130
Ramesh C. Chandan, Akanksha Gandhi, Nagendra P. Shah. Yogurt in Health and Disease Prevention2017; : 3 doi: 10.1016/B978-0-12-805134-4.00001-8
131
Emidio Scarpellini, Sharmila Fagoonee, Emanuele Rinninella, Carlo Rasetti, Isabella Aquila, Tiziana Larussa, Pietrantonio Ricci, Francesco Luzza, Ludovico Abenavoli. Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 PandemicJournal of Clinical Medicine 2020; 9(8): 2488 doi: 10.3390/jcm9082488
132
Meng-Wei Xiao, Shi-Xin Lin, Zhao-Hua Shen, Wei-Wei Luo, Xiao-Yan Wang. Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver DiseaseGastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/1484598
133
Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Milad Daneshi-Maskooni, Mohammad-Javad Hosseinzadeh-Attar. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocolBMJ Open 2017; 7(7): e016914 doi: 10.1136/bmjopen-2017-016914
134
Jichun Zhao, Fengwei Tian, Nan Zhao, Qixiao Zhai, Hao Zhang, Wei Chen. Effects of probiotics on d -galactose-induced oxidative stress in plasma: A meta-analysis of animal modelsJournal of Functional Foods 2017; 39: 44 doi: 10.1016/j.jff.2017.09.055
135
Robert S. Lo, Andrew S. Austin, Jan G. Freeman. Is There a Role for Probiotics in Liver Disease?The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/874768
136
H. Jin, X. Xu, B. Pang, R. Yang, H. Sun, C. Jiang, D. Shao, J. Shi. Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysisBeneficial Microbes 2021; : 1 doi: 10.3920/BM2020.0183
137
Mohamad Hizami Mohamad Nor, Nurainina Ayob, Norfilza M. Mokhtar, Raja Affendi Raja Ali, Geok Chin Tan, Zhiqin Wong, Nor Hamizah Shafiee, Yin Ping Wong, Muaatamarulain Mustangin, Khairul Najmi Muhammad Nawawi. The Effect of Probiotics (MCP® BCMC® Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver DiseaseNutrients 2021; 13(9): 3192 doi: 10.3390/nu13093192
138
Jin Imai, Sho Kitamoto, Nobuhiko Kamada. The pathogenic oral–gut–liver axis: new understandings and clinical implicationsExpert Review of Clinical Immunology 2021; 17(7): 727 doi: 10.1080/1744666X.2021.1935877
139
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiotaMetabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
140
Norberto C. Chávez-Tapia, Leticia González-Rodríguez, MinSeung Jeong, Yanine López-Ramírez, Varenka Barbero-Becerra, Eva Juárez-Hernández, Juan L. Romero-Flores, Marco Arrese, Nahúm Méndez-Sánchez, Misael Uribe. Current evidence on the use of probiotics in liver diseasesJournal of Functional Foods 2015; 17: 137 doi: 10.1016/j.jff.2015.05.009
141
Bobae Kim, Jeonghyeon Kwon, Min-Seok Kim, Haryung Park, Yosep Ji, Wilhelm Holzapfel, Chang-Kee Hyun, Marcia B. Aguila. Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in micePLOS ONE 2018; 13(12): e0210120 doi: 10.1371/journal.pone.0210120
142
Leila Javadi, Mostafa Ghavami, Manouchehr Khoshbaten, Abdolrasoul Safaiyan, Abolfazl Barzegari, Bahram Pourghassem Gargari. The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical TrialIranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.46017
143
E. B. Mitchel, J. E. Lavine. Review article: the management of paediatric nonalcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2014; 40(10): 1155 doi: 10.1111/apt.12972
144
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry2019; : 387 doi: 10.1016/B978-0-08-100596-5.21759-9
145
Pietro Vajro, Marco Poeta, Luca Pierri, Cristina Pizza, Roberta D’Aniello, Maria Sangermano, Grazia Massa, Giulia Paolella. Nutrition in the Prevention and Treatment of Abdominal Obesity2014; : 363 doi: 10.1016/B978-0-12-407869-7.00033-7
146
Julian R Marchesi, David H Adams, Francesca Fava, Gerben D A Hermes, Gideon M Hirschfield, Georgina Hold, Mohammed Nabil Quraishi, James Kinross, Hauke Smidt, Kieran M Tuohy, Linda V Thomas, Erwin G Zoetendal, Ailsa Hart. The gut microbiota and host health: a new clinical frontierGut 2016; 65(2): 330 doi: 10.1136/gutjnl-2015-309990
147
Gregor Lorbek, Žiga Urlep, Damjana Rozman. Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver diseasePharmacogenomics 2016; 17(11): 1273 doi: 10.2217/pgs-2016-0047
148
Mehran Rahimlou, Hoda Ahmadnia, Azita Hekmatdoost. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the futureWorld Journal of Hepatology 2015; 7(25): 2597-2602 doi: 10.4254/wjh.v7.i25.2597
149
Angelica Carreira dos Santos, Daniel Araki Ribeiro, Jessica Almeida da Cruz Ferreira, Odair Aguiar, Dan Linetzky Waitzberg, Claudia Cristina Alves. Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental nonalcoholic fatty liver diseaseNutrition & Food Science 2019; 49(1): 75 doi: 10.1108/NFS-04-2018-0119
150
Silvia M. Ferolla. Obesity2016; : 159 doi: 10.1007/978-3-319-19821-7_13
151
Sang Hak Han, Ki Tae Suk, Dong Joon Kim, Moon Young Kim, Soon Koo Baik, Young Don Kim, Gab Jin Cheon, Dae Hee Choi, Young Lim Ham, Dong Hoon Shin, Eun Ji Kim. Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitisEuropean Journal of Gastroenterology & Hepatology 2015; 27(11): 1300 doi: 10.1097/MEG.0000000000000458
152
Lucio Capurso. Thirty Years of Lactobacillus rhamnosus GGJournal of Clinical Gastroenterology 2019; 53(Supplement 1): S1 doi: 10.1097/MCG.0000000000001170
153
Ahad Eshraghian. Current and emerging pharmacological therapy for non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(42): 7495-7504 doi: 10.3748/wjg.v23.i42.7495
154
K A Aitbaev, I T Murkamilov, V V Fomin. Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulationTerapevticheskii arkhiv 2017; 89(8): 120 doi: 10.17116/terarkh2017898120-128
155
Salman Shirvani-Rad, Ozra Tabatabaei-Malazy, Shahrzad Mohseni, Shirin Hasani-Ranjbar, Ahmad-Reza Soroush, Zahra Hoseini-Tavassol, Hanieh-Sadat Ejtahed, Bagher Larijani, Vincenzo De Feo. Probiotics as a Complementary Therapy for Management of Obesity: A Systematic ReviewEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6688450
156
Suzanne R Sharpton, Bharat Maraj, Emily Harding-Theobald, Eric Vittinghoff, Norah A Terrault. Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regressionThe American Journal of Clinical Nutrition 2019; 110(1): 139 doi: 10.1093/ajcn/nqz042
157
Jennifer E. Lambert, Jill A. Parnell, Bertus Eksteen, Maitreyi Raman, Marc R. Bomhof, Kevin P. Rioux, Karen L. Madsen, Raylene A. Reimer. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocolBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0400-5
158
Felipe Galvão Batista Chaves, Glauco Ferreira de Oliveira, João Paulo Ribeiro, João Victor Serafim, Luiz Felipe Medeiros Cordeiro, Matheus Alves Alvares, Marcelo Trindade Cecchi, Murilo Cordeiro Vasquez, Thaísy Bianka Dorta de Souza, Vera Esteves Vagnozzi Rullo. THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEWRevista Paulista de Pediatria 2021; 39 doi: 10.1590/1984-0462/2021/39/2019226
159
Yolanda Sánchez-Torrijos, Leticia Álvarez-Amor, Rocío Aller, Pedro Pablo García-Luna, Franz Martín, Manuel Romero-Gómez. Non-Alcoholic Fatty Liver Disease2020; : 271 doi: 10.1007/978-3-319-95828-6_15
160
Jasmohan S. Bajaj, Alexander Khoruts. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosisJournal of Hepatology 2020; 72(5): 1003 doi: 10.1016/j.jhep.2020.01.017
161
Myungsuk Kim, Young Gyun Park, Hee-Ju Lee, Sue Ji Lim, Hong Ryul Ahn, Sang Hoon Jung, Chu Won Nho. Youngia denticulata attenuates diet-induced obesity-related metabolic dysfunctions by activating AMP-activated protein kinase and regulating lipid metabolismJournal of Functional Foods 2015; 18: 714 doi: 10.1016/j.jff.2015.09.002
162
Angela Horvath, Bettina Leber, Nicole Feldbacher, Markus Steinwender, Irina Komarova, Florian Rainer, Andreas Blesl, Vanessa Stadlbauer. The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59550-x
163
Hassan M. Heshmati. Advances in Hepatology2021;  doi: 10.5772/intechopen.97568
164
Juliana Paula Bruch-Bertani, Carolina Uribe-Cruz, Amanda Pasqualotto, Larisse Longo, Raquel Ayres, Carolina Bortolin Beskow, Afonso Luis Barth, Daiana Lima-Morales, Fábio Meurer, Gabriel Tayguara Silveira Guerreiro, Themis Reverbel da Silveira, Mário Reis Álvares-da-Silva, Valesca Dall’Alba. Hepatoprotective Effect of Probiotic Lactobacillus rhamnosus GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in ZebrafishJournal of the American College of Nutrition 2020; 39(2): 163 doi: 10.1080/07315724.2019.1627955
165
Kazunari Kadokura, Tsuyoshi Tomita, Kohei Suruga. Effect of fish paste products, fish balls ‘tsumire’, intake in Sprague–Dawley ratsJournal of Nutritional Science 2021; 10 doi: 10.1017/jns.2021.57
166
Reenam S. Khan, Fernando Bril, Kenneth Cusi, Philip N. Newsome. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver DiseaseHepatology 2019;  doi: 10.1002/hep.30429
167
Marco Toscano, Roberta De Grandi, Luca Pastorelli, Maurizio Vecchi, Lorenzo Drago. A consumer’s guide for probiotics: 10 golden rules for a correct useDigestive and Liver Disease 2017; 49(11): 1177 doi: 10.1016/j.dld.2017.07.011
168
Saba Mohammadi, Fatemeh Rostamkhani, Shahin Riyahi Malayeri, Hossein Shirvani. High-intensity interval training with probiotic supplementation decreases gene expression of NF-κβ and CXCL2 in small intestine of rats with steatosisSport Sciences for Health 2021;  doi: 10.1007/s11332-021-00829-5
169
Bobae Kim, Kun-Young Park, Yosep Ji, Soyoung Park, Wilhelm Holzapfel, Chang-Kee Hyun. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese miceBiochemical and Biophysical Research Communications 2016; 473(2): 530 doi: 10.1016/j.bbrc.2016.03.107
170
Gaeun Kim, Soon Koo Baik. Overview and recent trends of systematic reviews and meta-analyses in hepatologyClinical and Molecular Hepatology 2014; 20(2): 137 doi: 10.3350/cmh.2014.20.2.137
171
Nearmeen M. Rashad, Amal S. El-Shal, Abdelaziz I. Amin, Manar H. Soliman. Effects of probiotics supplementation on macrophage migration inhibitory factor and clinical laboratory feature of polycystic ovary syndromeJournal of Functional Foods 2017; 36: 317 doi: 10.1016/j.jff.2017.06.029
172
Xiaolin Gao, Yu Zhu, Yang Wen, Guanjian Liu, Chaomin Wan. Efficacy of probiotics in non-alcoholic fatty liver disease in adult and children: A meta-analysis of randomized controlled trialsHepatology Research 2016; 46(12): 1226 doi: 10.1111/hepr.12671
173
Fredrik Rosqvist, Andreas Rydell, David Iggman. The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)—A Systematic Review and Meta-AnalysisFrontiers in Nutrition 2020; 7 doi: 10.3389/fnut.2020.613221
174
Hessah Mohammed Al-muzafar, Kamal Adel Amin. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkersBMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-016-1540-z
175
Luis Vitetta, Sean Hall, Samantha Coulson. Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage InfluencesMicroorganisms 2015; 3(4): 913 doi: 10.3390/microorganisms3040913
176
Lu-Lu Gao, Yu-Xiang Li, Jia-Min Ma, Yi-Qiong Guo, Lin Li, Qing-Han Gao, Yan-Na Fan, Meng-Wei Zhang, Xiu-Juan Tao, Jian-Qiang Yu, Jian-Jun Yang. Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trialTrials 2021; 22(1) doi: 10.1186/s13063-021-05529-6
177
Jin-Chul Kim, Joo-Yeong Jeon, Woong-suk Yang, Cheorl-Ho Kim, Dae-Woon Eom. Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver DiseaseCurrent Pharmaceutical Biotechnology 2019; 20(3): 222 doi: 10.2174/1389201020666190311143554
178
Nwe Ni Than, Philip N. Newsome. A concise review of non-alcoholic fatty liver diseaseAtherosclerosis 2015; 239(1): 192 doi: 10.1016/j.atherosclerosis.2015.01.001
179
Christopher Irwin, Saman Khalesi, Amanda J. Cox, Gary Grant, Andrew K. Davey, Andrew C. Bulmer, Ben Desbrow. Effect of 8-weeks prebiotics/probiotics supplementation on alcohol metabolism and blood biomarkers of healthy adults: a pilot studyEuropean Journal of Nutrition 2018; 57(4): 1523 doi: 10.1007/s00394-017-1437-8
180
Parth J Parekh, Luis A Balart, David A Johnson. The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal DiseaseClinical and Translational Gastroenterology 2015; 6(6): e91 doi: 10.1038/ctg.2015.16
181
Yu. M. Stepanov, N. V. Chaliy. INFLUENCE OF SMALL INTESTINAL BACTERIAL OVERGROWTH ON THE COMPLICATIONS OF PORTAL HYPERTENSION IN ITS VARIOUS FORMS Bulletin of Problems Biology and Medicine 2018; (144): 195 doi: 10.29254/2077-4214-2018-1-2-143-195-198
182
Silvia Marinho Ferolla, Geyza Nogueira de Almeida Armiliato, Cláudia Alves Couto, Teresa Cristina Abreu Ferrari. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver diseaseWorld Journal of Hepatology 2015; 7(3): 559-565 doi: 10.4254/wjh.v7.i3.559
183
Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?Journal of Digestive Diseases 2019; 20(6): 271 doi: 10.1111/1751-2980.12751
184
Anna Jeznach-Steinhagen, Joanna Ostrowska, Aneta Czerwonogrodzka-Senczyna, Iwona Boniecka, Urszula Shahnazaryan, Alina Kuryłowicz. Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver DiseaseMedicina 2019; 55(5): 166 doi: 10.3390/medicina55050166
185
Yasuhiko Sawada, Hideto Kawaratani, Takuya Kubo, Yukihisa Fujinaga, Masanori Furukawa, Soichiro Saikawa, Shinya Sato, Kenichiro Seki, Hiroaki Takaya, Yasushi Okura, Kosuke Kaji, Naotaka Shimozato, Tsuyoshi Mashitani, Mitsuteru Kitade, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitisHepatology Research 2019; 49(3): 284 doi: 10.1111/hepr.13281
186
Somayyeh Firouzi, Barakatun-Nisak Mohd-Yusof, Hazreen-Abd Majid, Amin Ismail, Nor-Azmi Kamaruddin. Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trialBMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0952-5
187
Qingqing Zhang, Yucheng Wu, Xiaoqiang Fei. Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trialsMedicina 2016; 52(1): 28 doi: 10.1016/j.medici.2015.11.008
188
Paraskevas Gkolfakis, George Dimitriadis, Konstantinos Triantafyllou. Gut microbiota and non-alcoholic fatty liver diseaseHepatobiliary & Pancreatic Diseases International 2015; 14(6): 572 doi: 10.1016/S1499-3872(15)60026-1
189
Naga S. Betrapally, Patrick M. Gillevet, Jasmohan S. Bajaj. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?Gastroenterology 2016; 150(8): 1745 doi: 10.1053/j.gastro.2016.02.073
190
Irina A. Kirpich, Luis S. Marsano, Craig J. McClain. Gut–liver axis, nutrition, and non-alcoholic fatty liver diseaseClinical Biochemistry 2015; 48(13-14): 923 doi: 10.1016/j.clinbiochem.2015.06.023
191
Jerome Boursier, Anna Mae Diehl. Nonalcoholic Fatty Liver Disease and the Gut MicrobiomeClinics in Liver Disease 2016; 20(2): 263 doi: 10.1016/j.cld.2015.10.012
192
Barry A. Mizock. ProbioticsDisease-a-Month 2015; 61(7): 259 doi: 10.1016/j.disamonth.2015.03.011
193
Marica Meroni, Miriam Longo, Paola Dongiovanni. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic StrategiesNutrients 2019; 11(11): 2642 doi: 10.3390/nu11112642
194
Maurizio Koch. Gut Microbiota and the LiverJournal of Clinical Gastroenterology 2016; 50(Supplement 2): S183 doi: 10.1097/MCG.0000000000000699
195
S. Gitto, G. Vitale, E. Villa, P. Andreone. Treatment of Nonalcoholic Steatohepatitis in Adults: Present and FutureGastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/732870